Understanding urinary stone disease in children
Stone Disease of the Urinary Tract in Children: Clinical Presentation, Diagnostic Methods, Therapeutic Management, Evolution and Prognosis
This study looks at how common urinary stones are in children and what factors might affect their development to help improve treatment and prevention.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 140 (estimated) |
| Ages | 1 Year to 17 Years |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06032364 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the incidence and characteristics of urinary stone disease in children, focusing on factors such as race, geographic region, socio-economic status, and dietary habits. It highlights the prevalence of different types of urinary stones, particularly oxalo-calcium stones, and the importance of accurate diagnosis through imaging techniques. The study also seeks to identify risk factors for disease recurrence, including underlying urinary metabolic abnormalities and age, to improve management strategies for affected pediatric patients.
Who should consider this trial
Good fit: Ideal candidates for this study are children under 18 years old who have been diagnosed with urinary stone disease.
Not a fit: Patients who do not have urinary stone disease or whose data is insufficient for analysis may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and management of urinary stone disease in children, potentially reducing recurrence rates.
How similar studies have performed: While this study focuses on a specific pediatric population, similar studies in adults have shown success in understanding and managing urinary stone disease, suggesting potential for valuable insights in children as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Patients aged less than 18 years. * Both sexes. * Subjects presenting with lithiasis of the urinary tree in one of the two departments concerned between 01/01/2010 and 12/31/2022 * Subject not opposing, after information, the reuse of their data for the purposes of this research. * Holders of parental authority who do not object, after being informed, to the reuse of their child's data for the purposes of this research. Exclusion criteria: * Subject or holder of parental authority having expressed opposition to participating in the study. * Non-usable patient files: insufficient data.
Where this trial is running
Strasbourg
- Service de Pédiatrie 1 - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Isabelle TALON, MD
- Email: Isabelle.TALON@chru-strasbourg.fr
- Phone: 33 3 88 12 72 96
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.